basiliximab

• Product Name:basiliximab
• Synonyms: basiliximab
• CAS:
• MF:
• MW:0
• EINECS:
• Mol File:Mol File
• 

Basiliximab (Simulect, Chimeric) is an MAb produced by amouse monoclonal cell line that has been engineered to producethe basiliximab IgG1 κ antibody glycoprotein. Theproduct is chimeric (murine/human). Basiliximab is indicatedfor prophylaxis of acute organ rejection in patients receivingrenal transplantation when used as part of a regimenof immunosuppressants and corticosteroids. Basiliximab isalso indicated in pediatric renal transplantation.Basiliximab specifically binds to the IL-2 receptor α-chain(the CD25 antigen, part of the three-component IL-2α receptorsite). These sites are expressed on the surfaces of activatedT lymphocytes. Once bound, it blocks the IL-2α receptor withextremely high affinity. This specific, high-affinity binding toIL-2 competitively inhibits IL-2-mediated activation of lymphocytes,a critical event in the cellular immune response inallograft rejection.

• Company Name:Guangzhou Hongyuan Chemical Co.,Ltd
• Tel: 15817493340
• Products Intro:Product Name:Basiliximab
  Purity:95%
• CB Index:58
• Related Information:Catalog(1566)